Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

Recruiting now

Conditions studied: Migraine, Patent Foramen Ovale

In brief

To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.

Key facts

Study ID

NCT06953622

Run by

Peking University Third Hospital

People needed

330

Starts

2024-01-01

Expected to finish

2026-12-31

Last updated by the study team

2025-05-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3);
• Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography
• Agree to participate in the study and sign the informed consent form.

You may not qualify if…

• Can not sign the informed consent form or cooperate with follow-up.

Where it is running

• Peking University Third Hospital — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.